Arcadia Biosciences's total assets for Q3 2024 were $15.24M, a decrease of -12.25% from the previous quarter. RKDA total liabilities were $5.09M for the fiscal quarter, a -12.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.